IND-005

N/A

Report date: 2025/01/26 16:37:45

Base Information

Drug NameIND-005
Drug Alias NameImmunNovative-01Combpath-5.0recombinant soluble human CD5 (ImmunNovative)rshCD5 (ImmunNovative)IND-005
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionT-cell surface glycoprotein CD5 modulators
TargetsT-cell surface glycoprotein CD5
Therapy Area/IndicationsNeoplasmsSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunNovative Developments SL
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasmsSepsis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A